C E Dean

Summary

Country: USA

Publications

  1. ncbi Personalized medicine: boon or budget-buster?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Ann Pharmacother 43:958-62. 2009
  2. ncbi Prasterone (DHEA) and mania
    C E Dean
    Minneapolis Veteran s Affairs Medical Center, University of Minnesota Department of Psychiatry, 55417, USA
    Ann Pharmacother 34:1419-22. 2000
  3. ncbi Imipramine-associated hyperpigmentation
    Charles E Dean
    Tardive Dyskinesia Clinic, Minneapolis Veterans Affairs Medical Center and School of Medicine, University of Minnesota, Minneapolis, MN 55417 2309, USA
    Ann Pharmacother 37:825-8. 2003
  4. ncbi Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis VA Medical Center, MH PSL, 116A, Minneapolis, MN 55417, USA
    J Clin Psychopharmacol 24:298-304. 2004
  5. ncbi Mortality and tardive dyskinesia: long-term study using the US National Death Index
    Charles E Dean
    Mental Health Service Line, 116A, One Veterans Drive, Minneapolis, MN 55417, USA
    Br J Psychiatry 194:360-4. 2009
  6. ncbi Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions
    Charles E Dean
    Psychiatric Movement Disorders Clinic, Minneapolis Veterans Affairs Medical Center, MN 55417, USA
    J Clin Psychopharmacol 26:560-5. 2006
  7. ncbi Case study: childhood-onset tardive dyskinesia versus choreoacanthocytosis
    C M Borchardt
    Division of Child and Adolescent Psychiatry, University of Minnesota Medical School, Minneapolis, USA
    J Am Acad Child Adolesc Psychiatry 39:1055-8. 2000
  8. ncbi Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis VA Medical Center, One Veterans Drive, Minneapolis Minnesota 55417, USA
    Prog Neuropsychopharmacol Biol Psychiatry 30:174-89. 2006
  9. ncbi Psychiatry revisited
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis Veterans Affairs Medical Center, USA
    Minn Med 91:41-5. 2008
  10. ncbi Mortality and poststroke depression
    Charles E Dean
    Am J Psychiatry 161:1506; author reply 1507-8. 2004

Collaborators

Detail Information

Publications11

  1. ncbi Personalized medicine: boon or budget-buster?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Ann Pharmacother 43:958-62. 2009
    ..Given the current economic crisis, the time is ripe for a debate on this issue...
  2. ncbi Prasterone (DHEA) and mania
    C E Dean
    Minneapolis Veteran s Affairs Medical Center, University of Minnesota Department of Psychiatry, 55417, USA
    Ann Pharmacother 34:1419-22. 2000
    ..To inform clinicians and investigators of the potential for severe mania in conjunction with the use of prasterone (DHEA; dehydroepiandrosterone)...
  3. ncbi Imipramine-associated hyperpigmentation
    Charles E Dean
    Tardive Dyskinesia Clinic, Minneapolis Veterans Affairs Medical Center and School of Medicine, University of Minnesota, Minneapolis, MN 55417 2309, USA
    Ann Pharmacother 37:825-8. 2003
    ..To inform clinicians of the potential for severe and persistent facial hyperpigmentation with the long-term use of imipramine...
  4. ncbi Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis VA Medical Center, MH PSL, 116A, Minneapolis, MN 55417, USA
    J Clin Psychopharmacol 24:298-304. 2004
    ..We also hypothesized that the DISCUS, by virtue of its more detailed protocol, would be more sensitive than the AIMS...
  5. ncbi Mortality and tardive dyskinesia: long-term study using the US National Death Index
    Charles E Dean
    Mental Health Service Line, 116A, One Veterans Drive, Minneapolis, MN 55417, USA
    Br J Psychiatry 194:360-4. 2009
    ..Whether the development of tardive dyskinesia leads to an increase in mortality is still unclear...
  6. ncbi Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions
    Charles E Dean
    Psychiatric Movement Disorders Clinic, Minneapolis Veterans Affairs Medical Center, MN 55417, USA
    J Clin Psychopharmacol 26:560-5. 2006
    ..Increasing age and a lower score on the MMSE seem to be particularly helpful in gauging the risk for parkinsonian and dyskinetic movements...
  7. ncbi Case study: childhood-onset tardive dyskinesia versus choreoacanthocytosis
    C M Borchardt
    Division of Child and Adolescent Psychiatry, University of Minnesota Medical School, Minneapolis, USA
    J Am Acad Child Adolesc Psychiatry 39:1055-8. 2000
    ..However, this is unusually young age of onset for these conditions. Differential diagnosis, medication management of the movement disorder, and pathophysiological mechanisms in tardive dyskinesia and choreoacanthocytosis are discussed...
  8. ncbi Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis VA Medical Center, One Veterans Drive, Minneapolis Minnesota 55417, USA
    Prog Neuropsychopharmacol Biol Psychiatry 30:174-89. 2006
    ..We shall explore possible explanations for this apparent paradox...
  9. ncbi Psychiatry revisited
    Charles E Dean
    Tardive Dyskinesia Assessment Clinic, Minneapolis Veterans Affairs Medical Center, USA
    Minn Med 91:41-5. 2008
  10. ncbi Mortality and poststroke depression
    Charles E Dean
    Am J Psychiatry 161:1506; author reply 1507-8. 2004
  11. ncbi Ziprasidone-associated mania: a review and report of 2 additional cases
    Anne M Keating
    University of Minnesota School of Medicine, Minneapolis, USA
    Clin Neuropharmacol 28:83-6. 2005
    ..Clinicians and patients need to be aware of the potential for the induction of mania with ziprasidone, even after lengthy exposure...